Silo Pharma Files Provisional Patent for Ibogaine-Based Therapeutic Targeting Traumatic Brain Injury

Go back to Silo Pharma Files Provisional Patent for Ibogaine-Based Therapeutic Targeting Traumatic Brain Injury
(NASDAQ: SILO) Delayed: 6.65 +0.21 (3.26%)
Previous Close $6.44    52 Week High
Open $6.53    52 Week Low
Day High $6.65    P/E N/A 
Day Low $6.49    EPS
Volume 7,874